Efficient preparation of secondary aminoalcohols through a Ti(IV) reductive amination procedure. Application to the synthesis and antibacterial evaluation of new 3β-N-[hydroxyalkyl]aminosteroid derivatives
作者:Chanaz Salmi、Céline Loncle、Yves Letourneux、Jean Michel Brunel
DOI:10.1016/j.tet.2008.02.055
日期:2008.5
An efficient method for the synthesis of various secondary aminoalcohols through a titanium(IV) isopropoxide-mediated reductive amination reaction of ketones is reported. Thus, different ketones gave the expected products in moderate to excellent yields up to 89% in numerous cases. A series of 3 beta-N-[hydroxyalkyl]aminosteroid derivatives were prepared according to this methodology and evaluated for their in vitro antimicrobial properties against human pathogens. All the compounds showed moderate to excellent activities against Gram-positive bacteria exhibiting similar results against Staphylococcus aureus and Streptococcus faecalis with Minimum Inhibitory Concentrations (MICs) varying from 3.12 to 25 mu g/mL. No significant antibacterial activities are encountered against Gram-negative bacteria. (c) 2008 Elsevier Ltd. All rights reserved.
Sreekumar R.; Pillai, R. B. C.; Pillai, C. N., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1994, vol. 33, # 7, p. 692 - 693
作者:Sreekumar R.、Pillai, R. B. C.、Pillai, C. N.
DOI:——
日期:——
LIVER X RECEPTOR MODULATORS
申请人:Vitae Pharmaceuticals, Inc.
公开号:US20170136017A1
公开(公告)日:2017-05-18
Provided herein are novel compounds and pharmaceutically acceptable salts thereof that are liver X receptor modulators. Also provided are compositions comprising compounds of the invention and a carrier. Additionally, use of the compounds herein and methods for treating a disease or disorder associated with the liver X receptor are further described.
COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS
申请人:Vitae Pharmaceuticals, Inc.
公开号:US20170231992A1
公开(公告)日:2017-08-17
Provided herein are compounds and pharmaceutically acceptable salts thereof that are useful therapeutics for acute coronary syndrome and related disorders.